Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.2 | 0.002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 0.002 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |